Literature DB >> 23514809

Role of cytokines and Jak3/Stat3 signaling in the 1,2-dimethylhydrazine dihydrochloride-induced rat model of colon carcinogenesis: early target in the anticancer strategy.

Manpreet Kaur Saini1, Vivek Vaish, Sankar Nath Sanyal.   

Abstract

The molecular mechanisms by which colon cancer cells regulate the expression of various proinflammatory and anti-inflammatory cytokines and transcription factors resulting in tumor progression have not been well clarified. The present study thus explores the effect of cancer cell-derived cytokines and transcription factors on the chemoprevention of a rat model of early colon carcinogenesis. Elevated expression of proinflammatory cytokines [interleukin-1β (IL-1β), IL-2, interferon γ, and tumor necrosis factor-α] and the transcription factors [Janus kinase 3 (Jak3) and signal transducer and activator of transcription 3 (Stat3)] was found in the 1,2-dimethylhydrazine dihydrochloride (DMH) group; however, this elevated expression was reversed by the individual and combination treatment with piroxicam, a traditional nonsteroidal anti-inflammatory drug [inhibiting both cyclooxygenase-1 (COX-1) and COX-2] and c-phycocyanin, a cyanobacterium-derived biliprotein from Spirulina platensis (selective COX-2 inhibitor). In the DMH group, low expression of IL-4, an anti-inflammatory cytokine, was further observed with respect to the other groups. Expression of inducible nitric oxide synthase and nitric oxide/citrulline levels was also analyzed and was found to be elevated with DMH treatment. Increased apoptotic index and stimulated levels of Bcl-2-associated death promoter (Bad), a proapoptotic protein, were observed in piroxicam-treated and c-phycocyanin-treated rats. In-silico molecular docking of piroxicam as a ligand with several regulatory proteins was performed, indicating that, except inducible nitric oxide synthase, it effectively binds with COX-1, COX-2, Jak3, and Stat3. Piroxicam and c-phycocyanin perhaps showed chemopreventive properties by inhibiting proinflammatory cytokines and Jak3/Stat3 signaling while promoting apoptosis. In addition, a combination regimen was found to be more beneficial than monotherapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23514809     DOI: 10.1097/CEJ.0b013e3283584932

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  10 in total

1.  Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by Diclofenac and Curcumin in colon cancer.

Authors:  Chandan Rana; Honit Piplani; Vivek Vaish; Bimla Nehru; S N Sanyal
Journal:  Mol Cell Biochem       Date:  2015-02-03       Impact factor: 3.396

2.  Artificial intelligence-assisted development of in situ forming nanoparticles for arthritis therapy via intra-articular delivery.

Authors:  Ahmed S Yacoub; Hussein O Ammar; Magdy Ibrahim; Suzan M Mansour; Nada M El Hoffy
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

3.  Modulating the Growth, Antioxidant Activity, and Immunoexpression of Proinflammatory Cytokines and Apoptotic Proteins in Broiler Chickens by Adding Dietary Spirulina platensis Phycocyanin.

Authors:  Anaam E Omar; Hanan S Al-Khalaifah; Ali Osman; Ahmed Gouda; Shimaa I Shalaby; Elshimaa M Roushdy; Samar A Abdo; Sozan A Ali; Aziza M Hassan; Shimaa A Amer
Journal:  Antioxidants (Basel)       Date:  2022-05-19

4.  A novel mechanism of skin tumor promotion involving interferon-gamma (IFNγ)/signal transducer and activator of transcription-1 (Stat1) signaling.

Authors:  Ronald Bozeman; Erika L Abel; Everardo Macias; Tianyi Cheng; Linda Beltran; John DiGiovanni
Journal:  Mol Carcinog       Date:  2014-01-25       Impact factor: 4.784

5.  In vivo and in vitro immunomodulatory potential of swertiamarin isolated from Enicostema axillare (Lam.) A. Raynal that acts as an anti-inflammatory agent.

Authors:  S Saravanan; P Pandikumar; N Prakash Babu; V I Hairul Islam; K Thirugnanasambantham; M Gabriel Paulraj; K Balakrishna; S Ignacimuthu
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

6.  Phycocyanin Ameliorates Colitis-Associated Colorectal Cancer by Regulating the Gut Microbiota and the IL-17 Signaling Pathway.

Authors:  Dongjin Pan; Bingyao Huang; Yuman Gan; Chenghai Gao; Yonghong Liu; Zhenzhou Tang
Journal:  Mar Drugs       Date:  2022-04-09       Impact factor: 6.085

7.  C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.

Authors:  Nissar Wani; Mohd W Nasser; Dinesh K Ahirwar; Helong Zhao; Zhenhua Miao; Konstantin Shilo; Ramesh K Ganju
Journal:  Breast Cancer Res       Date:  2014-05-29       Impact factor: 6.466

Review 8.  Medical Application of Spirulina platensis Derived C-Phycocyanin.

Authors:  Qian Liu; Yinghong Huang; Ronghua Zhang; Tiange Cai; Yu Cai
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-11       Impact factor: 2.629

Review 9.  Phycocyanin: A Potential Drug for Cancer Treatment.

Authors:  Liangqian Jiang; Yujuan Wang; Qifeng Yin; Guoxiang Liu; Huihui Liu; Yajing Huang; Bing Li
Journal:  J Cancer       Date:  2017-09-20       Impact factor: 4.207

10.  L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs.

Authors:  Małgorzata Krzystek-Korpacka; Berenika Szczęśniak-Sięga; Izabela Szczuka; Paulina Fortuna; Marek Zawadzki; Agnieszka Kubiak; Magdalena Mierzchała-Pasierb; Mariusz G Fleszar; Łukasz Lewandowski; Paweł Serek; Natalia Jamrozik; Katarzyna Neubauer; Jerzy Wiśniewski; Radosław Kempiński; Wojciech Witkiewicz; Iwona Bednarz-Misa
Journal:  Cancers (Basel)       Date:  2020-09-11       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.